Dr. Reddy’s Laboratories Ltd.’s Revenues Cross $2 Billion Milestone* in FY12

May 11, 2012 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its audited consolidated financial results for the quarter and full year ended March 31, 2012 under International Financial Reporting Standards (IFRS).

Twitter
LinkedIn
Facebook
Email
Print

Asia